It is known from literature that torasemide, generic name for N-1 isopropyl
-N-3-[4-(3-methylphenylamino)-3-pyridylsulphonyl]urea can have two polymorp
hic forms, denoted as T-I and T-II. A novel, third polymorph N of torasemid
e, T-N has been discovered and fully characterised. It crystallises in the
centrosymmetric monoclinic space group P2(1)/c with two crystallographicall
y independent molecules, which differ primarily in their different phenyl r
ing and N-1-isopropyl side chain orientations. Both independent molecules,
i.e. conformations, can adopt a zwitter-ionic structure. The new polymorph
of torasemide is characterised by a considerably complex three-dimensional
hydrogen-bonding network that spans all over the crystal unit cell. The cry
stal packing of T-N is rather crowded, dense and compact. It is pointed out
that the degree of crystal structure diversity of the existing torasemide
polymorphs is considerably high, with different conformational properties o
f distinct torasemide molecules in its asymmetric unit.